114 related articles for article (PubMed ID: 2744187)
1. Prolactin suppression by bromocriptine stimulates aromatization of testosterone to estradiol in women.
Martikainen H; Rönnberg L; Puistola U; Tapanainen J; Orava M; Kauppila A
Fertil Steril; 1989 Jul; 52(1):51-4. PubMed ID: 2744187
[TBL] [Abstract][Full Text] [Related]
2. Human menopausal gonadotropin/human chorionic gonadotropin-induced ovarian hyperstimulation with transient hyperprolactinemia: steroidogenesis enhanced during bromocriptine therapy in monkeys.
Collins RL; Williams RF; Hodgen GD
J Clin Endocrinol Metab; 1984 Oct; 59(4):727-33. PubMed ID: 6434577
[TBL] [Abstract][Full Text] [Related]
3. Suppression of prolactin secretion during ovarian hyperstimulation is followed by elevated serum levels of endometrial protein PP14 in the late luteal phase.
Seppälä M; Martikainen H; Rönnberg L; Riittinen L; Kauppila A
Hum Reprod; 1989 May; 4(4):389-91. PubMed ID: 2745669
[TBL] [Abstract][Full Text] [Related]
4. [The response of ovarian function to HMG-HCG and bromocriptine therapies in hyperprolactinemic patients].
Matsuoka M; Imura H; Aso T; Okuda K
Nihon Naibunpi Gakkai Zasshi; 1984 May; 60(5):647-58. PubMed ID: 6436078
[TBL] [Abstract][Full Text] [Related]
5. Hypoprolactinemia and ovarian function.
Kauppila A; Martikainen H; Puistola U; Reinilä M; Rönnberg L
Fertil Steril; 1988 Mar; 49(3):437-41. PubMed ID: 3342895
[TBL] [Abstract][Full Text] [Related]
6. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
[TBL] [Abstract][Full Text] [Related]
7. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
Parsanezhad ME; Alborzi S; Jahromi BN
Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
[TBL] [Abstract][Full Text] [Related]
8. Plasma gastrointestinal hormones during spontaneous and induced menstrual cycles.
Holst N; Jenssen TG; Burhol PG; Haug E; Forsdahl F
J Clin Endocrinol Metab; 1989 Jun; 68(6):1160-6. PubMed ID: 2498386
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia enhances ovarian estrogen responsiveness to gonadotropins in prepubertal rats: antagonistic effect of adrenalectomy.
Advis JP; Aguado LI; Ojeda SR
Biol Reprod; 1983 Aug; 29(1):181-94. PubMed ID: 6615964
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropins, prolactin, testosterone and estradiol in seminal plasma: effect of clomiphene treatment.
Rönnberg L; Kivinen S; Ylikorkala O
Andrologia; 1981; 13(5):406-11. PubMed ID: 6797324
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle.
Tsonis CG; Messinis IE; Templeton AA; McNeilly AS; Baird DT
J Clin Endocrinol Metab; 1988 May; 66(5):915-21. PubMed ID: 3129450
[TBL] [Abstract][Full Text] [Related]
12. Altered follicular development in clomiphene citrate versus human menopausal gonadotropin-stimulated cycles for in vitro fertilization.
Dlugi AM; Laufer N; Botero-Ruiz W; DeCherney AH; Polan ML; Haseltine FP; Mezer HC; Behrman HR
Fertil Steril; 1985 Jan; 43(1):40-7. PubMed ID: 3155509
[TBL] [Abstract][Full Text] [Related]
13. The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease.
Steingold KA; Lobo RA; Judd HL; Lu JK; Chang RJ
J Clin Endocrinol Metab; 1986 May; 62(5):1048-51. PubMed ID: 2937800
[TBL] [Abstract][Full Text] [Related]
14. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
15. Induction of ovulation in patients with normoprolactinemic amenorrhea by combined therapy with bromocriptine and clomiphene.
Koike K; Aono T; Miyake A; Tsutsumi H; Matsumoto K; Kurachi K
Fertil Steril; 1981 Feb; 35(2):138-41. PubMed ID: 6781935
[TBL] [Abstract][Full Text] [Related]
16. Circulating pituitary-gonadal hormones in clomiphene-induced cycles.
Dawood MY; Saxena BB
Obstet Gynecol; 1978 Oct; 52(4):445-50. PubMed ID: 714327
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells.
Tapanainen J; Martikainen H; Voutilainen R; Orava M; Ruokonen A; Rönnberg L
Fertil Steril; 1992 Oct; 58(4):726-32. PubMed ID: 1426317
[TBL] [Abstract][Full Text] [Related]
18. Prolactin concentrations in follicular fluid following ovarian hyperstimulation for in vitro fertilization.
Bohnet HG; Baukloh V
Horm Res; 1985; 22(3):189-95. PubMed ID: 4054838
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women.
Forsbach G; Soria J; Canales ES; Guzman V; Cabezas A; Zárate A
Obstet Gynecol; 1977 Aug; 50(2):139-44. PubMed ID: 327363
[TBL] [Abstract][Full Text] [Related]
20. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
Sherman BM; Chapler FK; Crickard K; Wycoff D
J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
